Meiji Yasuda Life Insurance CO Abbott Laboratories Transaction History

Meiji Yasuda Life Insurance CO

$5.39 Billion
Q3 2024

A detailed history of Meiji Yasuda Life Insurance CO transactions in Abbott Laboratories stock. As of the latest transaction made, Meiji Yasuda Life Insurance CO holds 20,197 shares of ABT stock, worth $2.38 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

20,197

Previous 20,662 2.25%

Holding current value

$2.38 Million

Previous $2.15 Million 7.27%

% of portfolio

0.04%

Previous 0.04%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$100.07 - $118.13 $46,532 - $54,930	-465 Reduced 2.25%	20,197 $2.3 Million
Q2 2024 Aug 12, 2024	SELL	$100.73 - $112.44 $4.3 Million - $4.8 Million	-42,665 Reduced 67.37%	20,662 $2.15 Million
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $549,133 - $606,493	5,014 Added 8.6%	63,327 $7.2 Million
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $1.13 Million - $1.38 Million	12,500 Added 27.28%	58,313 $6.42 Million
Q3 2023 Nov 13, 2023	BUY	$95.53 - $114.62 $723,735 - $868,361	7,576 Added 19.81%	45,813 $4.44 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $264,043 - $294,199	2,620 Added 7.36%	38,237 $4.17 Million
Q1 2023 May 10, 2023	BUY	$96.86 - $114.01 $11,429 - $13,453	118 Added 0.33%	35,617 $3.61 Million
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $5,893 - $6,914	-62 Reduced 0.17%	35,499 $3.9 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $442,386 - $512,201	4,572 Added 14.75%	35,561 $3.44 Million
Q2 2022 Aug 16, 2022	BUY	$102.07 - $123.37 $548,830 - $663,360	5,377 Added 20.99%	30,989 $3.37 Million
Q1 2022 May 17, 2022	SELL	$114.02 - $139.04 $932,683 - $1.14 Million	-8,180 Reduced 24.21%	25,612 $3.03 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $430,349 - $526,938	-3,725 Reduced 9.93%	33,792 $4.76 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $221,420 - $244,955	-1,898 Reduced 4.82%	37,517 $4.43 Million
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $107,905 - $127,020	-1,020 Reduced 2.52%	39,415 $4.57 Million
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $239,883 - $282,618	2,204 Added 5.76%	40,435 $4.85 Million
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $1.16 Million - $1.27 Million	-11,088 Reduced 22.48%	38,231 $4.19 Million
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $140,575 - $170,718	1,534 Added 3.21%	49,319 $5.37 Million
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $131,700 - $168,560	1,720 Added 3.73%	47,785 $4.37 Million
Q1 2020 May 14, 2020	SELL	$62.82 - $91.86 $113,892 - $166,542	-1,813 Reduced 3.79%	46,065 $3.64 Million
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $359,968 - $400,729	-4,585 Reduced 8.74%	47,878 $4.16 Million
Q3 2019 Nov 13, 2019	BUY	$81.84 - $88.74 $438,171 - $475,113	5,354 Added 11.37%	52,463 $4.39 Million
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $539,603 - $629,340	7,404 Added 18.65%	47,109 $3.96 Million
Q1 2019 May 14, 2019	SELL	$66.22 - $80.06 $412,881 - $499,174	-6,235 Reduced 13.57%	39,705 $3.17 Million
Q4 2018 Feb 12, 2019	BUY	$65.56 - $74.27 $32,976 - $37,357	503 Added 1.11%	45,940 $3.32 Million
Q3 2018 Nov 13, 2018	BUY	$60.81 - $73.36 $24,324 - $29,344	400 Added 0.89%	45,437 $3.33 Million
Q2 2018 Aug 13, 2018	BUY	$57.57 - $63.54 $389,173 - $429,530	6,760 Added 17.66%	45,037 $2.75 Million
Q1 2018 May 14, 2018	SELL	$56.27 - $63.62 $506,992 - $573,216	-9,010 Reduced 19.05%	38,277 $2.29 Million
Q4 2017 Feb 13, 2018	SELL	$53.68 - $57.47 $16,640 - $17,815	-310 Reduced 0.65%	47,287 $2.7 Million
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $2.29 Million - $2.55 Million	47,597	47,597 $2.54 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meiji Yasuda Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Meiji Yasuda Life Insurance CO with notifications on news.

Account

Meiji Yasuda Life Insurance CO Abbott Laboratories Transaction History